Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population: The Hoorn Study

Diabetes Care

Volumn 20, Issue 7, 1997, Pages 1108-1110

  Ruige, Johannes B ^a   Batstra, Manou R ^b   Aanstoot, Henk Jan ^b   Bouter, Lex M ^b   Bruining, G Jan ^b   De Neeling, J Nico D ^b   Heine, Robert J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSIS; ETIOLOGY; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE;

EID: 0030943493     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.7.1108     Document Type: Article

References (18)

1. Zimmet PZ: The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18:1050-1064, 1995
2. Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lemmark A: Quantitative assay using recombinant human islet glutamic acid decarbocylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1993
3. Niskanen LK, Tuomi T, Karjalainen JK, Groop LC, Uusitupa MIJ: GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 18:1557-1565, 1995
4. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Medicine 11:299-303, 1994
5. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, Heine RJ: Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. Diabetes Care 18:1270-1273, 1995
6. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T: Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467, 1994
7. Schmidli RS, Colman PG, Bonifacio E: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the Second International GADAB Workshop. Diabetes 44:636-640, 1995
8. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
9. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41:548-551, 1992
10. Seubert M, de Sonnaville JJJ, Moser L, Seissler J, Heine RJ: Prevalence and predictive value of GAD-antibodies in diabetes mellitus diagnosed above 40 years of age. Diabetologia 39 (Suppl. 1):A91-A338, 1996
11. Aanstoot HJ, Kang SM, Kim J, Lindsay L, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin M, Bruining J, Maclaren N, Akerblom HK, Baekkeskov S: Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and 1A2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 97:2772-2783, 1996
12. Aanstoot HJ, Petersen JS, Batstra MR, de Man S, Scholtens A, Jensen E, Molenaar JL, de Bruijn T, Grobbee D, Bruining GJ, Dryberg T: Low frequency of antibodies to glutamic acid decarboxylase in the general population. Diabetologia 38 (Suppl. 1): A54-A205, 1995
13. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y: Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Gin Pract 28:191-199, 1995
14. Park Y, Lee H, Koh CS, Min H, Rowley M, Mackay IR, Zimmet P, McCarthy B, McCanlies E, Dorman J, Trucco M: The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19:241-245, 1996
15. Dowse GK, Zimmet PZ, Spark RA, Mavo B, Rowley MJ, Mackay IR: Lack of antibodies to glutamic acid decarboxylase in young adults of the high diabetes prevalence Wanigela people of Papua New Guinea. Diabetes Res Clin Pract 24:195-198, 1994
16. Zimmet PZ, Shaten BJ, Kuller LH, Rowley MJ, Knowles WJ, Mackay IR: Antibodies to glutamic acid decarboxylase and diabetes mellitus in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 140:683-690, 1994
17. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385, 1994
18. Pietropaolo M, Hutton JC, Eisenbarth GS: Protein tyrosine phosphatase-like proteins: link with IDDM. Diabetes Care 20:208-214, 1997